An observational study after completion of a multicenter open-label uncontrolled trial in pleurodesis for secondary intractable pneumothorax with sterile graded talc
Not Applicable
Completed
- Conditions
- Patients who participated in an investigator-initiated phase II study in pleurodesis for secondary intractable pneumothorax with sterile graded talc (protocol number: J-TALC2) with absence of chest tube removal within 30 days after pleurodesis, and who still have been hospitalized.
- Registration Number
- JPRN-jRCT1091220271
- Lead Sponsor
- ational Hospital Organization Nagoya Medical Center Hideo Saka
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
(1)Participants in the investigator-initiated phase II study in pleurodesis for secondary intractable pneumothorax with sterile graded talc (protocol number: J-TALC2).
(2)Patients who provided written consents for this study by themselves.
Exclusion Criteria
(1)Patients who were discharged during the observation period of J-TALC2 clinical trial.
(2)Patients who discontinued participation during J-TALC2 trial period.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method (1)Presence or absence of discharge (discharge date in the case of presence, reason for discharge).<br>(2)Presence or absence of chest tube removal.<br>(3)Presence or absence of continuous treatment for pneumothorax.<br>(4)Other (death, etc.).
- Secondary Outcome Measures
Name Time Method